サマリー

呼吸器系疾患の治療薬を研究しています
市場の分析と洞察。呼吸器疾患用薬剤の世界市場
COVID-19の大流行により、呼吸器疾患治療薬の世界市場規模は2022年に百万米ドルと推定され、レビュー期間中にCAGR %で2028年までに百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年に呼吸器疾患薬の世界市場の％を占めたOTCは、2028年までに百万米ドルの価値を持ち、COVID-19以降の期間に修正された％のCAGRで成長すると予測されます。一方、病院セグメントは、この予測期間を通して％CAGRに変更されています。
中国の呼吸器疾患薬の市場規模は2021年に百万米ドル、米国と欧州の呼吸器疾患薬はそれぞれ百万米ドル、百万米ドルとなっています。2021年の米国の割合は％、中国と欧州はそれぞれ％、％であり、中国の割合は2028年には％に達すると予測され、分析期間を通じてCAGRは％であると追跡しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパの呼吸器疾患治療薬の展望については、ドイツは2028年までに100万米ドルに達すると予測され、予測期間中のCAGRは%となっています。

呼吸器疾患薬の世界的な主要メーカーは、バイオジェン、ファイザー、テバ、ノバルティス、ジョンソン＆ジョンソン、エリリー、大塚、メルク、アストラゼネカなどです。2021年、世界の上位5社は売上高で約 %のシェアを占めています。
生産面では、2017年から2022年まで、2028年までの予測で、メーカー別、地域別（地域レベル、国レベル）の呼吸器疾患治療薬の容量、生産量、成長率、市場シェアを調査しています。
販売面では、2017年から2022年までと2028年までの予測で、地域別（地域レベル、国レベル）、企業別、タイプ別、用途別の呼吸器疾患治療薬の販売に焦点を当てて調査しています。

世界の呼吸器疾患用薬剤の範囲とセグメント
呼吸器疾患治療薬市場は、タイプ別と用途別に分類されます。呼吸器疾患薬の世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017-2028年の期間において、タイプ別およびアプリケーション別の生産能力、収益、予測に焦点を当てています。

タイプ別セグメント
一般用医薬品
Rx医薬品
用途別セグメント
病院
小売店

会社別
バイオジェン
ファイザー
テバ
ノバルティス
ジョンソン・エンド・ジョンソン
イーライリリー
大塚製薬
メルク
アストラゼネカ
ノバルティス
武田薬品工業

地域別生産量
北米
欧州
中国
日本

地域別消費量
北米
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE

ページTOPに戻る

目次

1 Study Coverage
1.1 Respiratory Diseases Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Respiratory Diseases Drugs Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Respiratory Diseases Drugs Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Respiratory Diseases Drugs Production
2.1 Global Respiratory Diseases Drugs Production Capacity (2017-2028)
2.2 Global Respiratory Diseases Drugs Production by Region: 2017 VS 2021 VS 2028
2.3 Global Respiratory Diseases Drugs Production by Region
2.3.1 Global Respiratory Diseases Drugs Historic Production by Region (2017-2022)
2.3.2 Global Respiratory Diseases Drugs Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Respiratory Diseases Drugs Sales in Volume & Value Estimates and Forecasts
3.1 Global Respiratory Diseases Drugs Sales Estimates and Forecasts 2017-2028
3.2 Global Respiratory Diseases Drugs Revenue Estimates and Forecasts 2017-2028
3.3 Global Respiratory Diseases Drugs Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Respiratory Diseases Drugs Sales by Region
3.4.1 Global Respiratory Diseases Drugs Sales by Region (2017-2022)
3.4.2 Global Sales Respiratory Diseases Drugs by Region (2023-2028)
3.5 Global Respiratory Diseases Drugs Revenue by Region
3.5.1 Global Respiratory Diseases Drugs Revenue by Region (2017-2022)
3.5.2 Global Respiratory Diseases Drugs Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Respiratory Diseases Drugs Production Capacity by Manufacturers
4.2 Global Respiratory Diseases Drugs Sales by Manufacturers
4.2.1 Global Respiratory Diseases Drugs Sales by Manufacturers (2017-2022)
4.2.2 Global Respiratory Diseases Drugs Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Respiratory Diseases Drugs in 2021
4.3 Global Respiratory Diseases Drugs Revenue by Manufacturers
4.3.1 Global Respiratory Diseases Drugs Revenue by Manufacturers (2017-2022)
4.3.2 Global Respiratory Diseases Drugs Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Respiratory Diseases Drugs Revenue in 2021
4.4 Global Respiratory Diseases Drugs Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Respiratory Diseases Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Respiratory Diseases Drugs Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Respiratory Diseases Drugs Sales by Type
5.1.1 Global Respiratory Diseases Drugs Historical Sales by Type (2017-2022)
5.1.2 Global Respiratory Diseases Drugs Forecasted Sales by Type (2023-2028)
5.1.3 Global Respiratory Diseases Drugs Sales Market Share by Type (2017-2028)
5.2 Global Respiratory Diseases Drugs Revenue by Type
5.2.1 Global Respiratory Diseases Drugs Historical Revenue by Type (2017-2022)
5.2.2 Global Respiratory Diseases Drugs Forecasted Revenue by Type (2023-2028)
5.2.3 Global Respiratory Diseases Drugs Revenue Market Share by Type (2017-2028)
5.3 Global Respiratory Diseases Drugs Price by Type
5.3.1 Global Respiratory Diseases Drugs Price by Type (2017-2022)
5.3.2 Global Respiratory Diseases Drugs Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Respiratory Diseases Drugs Sales by Application
6.1.1 Global Respiratory Diseases Drugs Historical Sales by Application (2017-2022)
6.1.2 Global Respiratory Diseases Drugs Forecasted Sales by Application (2023-2028)
6.1.3 Global Respiratory Diseases Drugs Sales Market Share by Application (2017-2028)
6.2 Global Respiratory Diseases Drugs Revenue by Application
6.2.1 Global Respiratory Diseases Drugs Historical Revenue by Application (2017-2022)
6.2.2 Global Respiratory Diseases Drugs Forecasted Revenue by Application (2023-2028)
6.2.3 Global Respiratory Diseases Drugs Revenue Market Share by Application (2017-2028)
6.3 Global Respiratory Diseases Drugs Price by Application
6.3.1 Global Respiratory Diseases Drugs Price by Application (2017-2022)
6.3.2 Global Respiratory Diseases Drugs Price Forecast by Application (2023-2028)
7 North America
7.1 North America Respiratory Diseases Drugs Market Size by Type
7.1.1 North America Respiratory Diseases Drugs Sales by Type (2017-2028)
7.1.2 North America Respiratory Diseases Drugs Revenue by Type (2017-2028)
7.2 North America Respiratory Diseases Drugs Market Size by Application
7.2.1 North America Respiratory Diseases Drugs Sales by Application (2017-2028)
7.2.2 North America Respiratory Diseases Drugs Revenue by Application (2017-2028)
7.3 North America Respiratory Diseases Drugs Sales by Country
7.3.1 North America Respiratory Diseases Drugs Sales by Country (2017-2028)
7.3.2 North America Respiratory Diseases Drugs Revenue by Country (2017-2028)
7.3.3 the United States
7.3.4 Canada
8 Europe
8.1 Europe Respiratory Diseases Drugs Market Size by Type
8.1.1 Europe Respiratory Diseases Drugs Sales by Type (2017-2028)
8.1.2 Europe Respiratory Diseases Drugs Revenue by Type (2017-2028)
8.2 Europe Respiratory Diseases Drugs Market Size by Application
8.2.1 Europe Respiratory Diseases Drugs Sales by Application (2017-2028)
8.2.2 Europe Respiratory Diseases Drugs Revenue by Application (2017-2028)
8.3 Europe Respiratory Diseases Drugs Sales by Country
8.3.1 Europe Respiratory Diseases Drugs Sales by Country (2017-2028)
8.3.2 Europe Respiratory Diseases Drugs Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 UK
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Respiratory Diseases Drugs Market Size by Type
9.1.1 Asia Pacific Respiratory Diseases Drugs Sales by Type (2017-2028)
9.1.2 Asia Pacific Respiratory Diseases Drugs Revenue by Type (2017-2028)
9.2 Asia Pacific Respiratory Diseases Drugs Market Size by Application
9.2.1 Asia Pacific Respiratory Diseases Drugs Sales by Application (2017-2028)
9.2.2 Asia Pacific Respiratory Diseases Drugs Revenue by Application (2017-2028)
9.3 Asia Pacific Respiratory Diseases Drugs Sales by Region
9.3.1 Asia Pacific Respiratory Diseases Drugs Sales by Region (2017-2028)
9.3.2 Asia Pacific Respiratory Diseases Drugs Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Respiratory Diseases Drugs Market Size by Type
10.1.1 Latin America Respiratory Diseases Drugs Sales by Type (2017-2028)
10.1.2 Latin America Respiratory Diseases Drugs Revenue by Type (2017-2028)
10.2 Latin America Respiratory Diseases Drugs Market Size by Application
10.2.1 Latin America Respiratory Diseases Drugs Sales by Application (2017-2028)
10.2.2 Latin America Respiratory Diseases Drugs Revenue by Application (2017-2028)
10.3 Latin America Respiratory Diseases Drugs Sales by Country
10.3.1 Latin America Respiratory Diseases Drugs Sales by Country (2017-2028)
10.3.2 Latin America Respiratory Diseases Drugs Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Respiratory Diseases Drugs Market Size by Type
11.1.1 Middle East and Africa Respiratory Diseases Drugs Sales by Type (2017-2028)
11.1.2 Middle East and Africa Respiratory Diseases Drugs Revenue by Type (2017-2028)
11.2 Middle East and Africa Respiratory Diseases Drugs Market Size by Application
11.2.1 Middle East and Africa Respiratory Diseases Drugs Sales by Application (2017-2028)
11.2.2 Middle East and Africa Respiratory Diseases Drugs Revenue by Application (2017-2028)
11.3 Middle East and Africa Respiratory Diseases Drugs Sales by Country
11.3.1 Middle East and Africa Respiratory Diseases Drugs Sales by Country (2017-2028)
11.3.2 Middle East and Africa Respiratory Diseases Drugs Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Biogen
12.1.1 Biogen Corporation Information
12.1.2 Biogen Overview
12.1.3 Biogen Respiratory Diseases Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Biogen Respiratory Diseases Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Biogen Recent Developments
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Overview
12.2.3 Pfizer Respiratory Diseases Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Pfizer Respiratory Diseases Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Pfizer Recent Developments
12.3 Teva
12.3.1 Teva Corporation Information
12.3.2 Teva Overview
12.3.3 Teva Respiratory Diseases Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Teva Respiratory Diseases Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Teva Recent Developments
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Overview
12.4.3 Novartis Respiratory Diseases Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Novartis Respiratory Diseases Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Novartis Recent Developments
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Overview
12.5.3 Johnson & Johnson Respiratory Diseases Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Johnson & Johnson Respiratory Diseases Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Johnson & Johnson Recent Developments
12.6 EliLilly
12.6.1 EliLilly Corporation Information
12.6.2 EliLilly Overview
12.6.3 EliLilly Respiratory Diseases Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 EliLilly Respiratory Diseases Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 EliLilly Recent Developments
12.7 Otsuka
12.7.1 Otsuka Corporation Information
12.7.2 Otsuka Overview
12.7.3 Otsuka Respiratory Diseases Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Otsuka Respiratory Diseases Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Otsuka Recent Developments
12.8 Merck
12.8.1 Merck Corporation Information
12.8.2 Merck Overview
12.8.3 Merck Respiratory Diseases Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Merck Respiratory Diseases Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Merck Recent Developments
12.9 AstraZeneca
12.9.1 AstraZeneca Corporation Information
12.9.2 AstraZeneca Overview
12.9.3 AstraZeneca Respiratory Diseases Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 AstraZeneca Respiratory Diseases Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 AstraZeneca Recent Developments
12.10 Novartis
12.10.1 Novartis Corporation Information
12.10.2 Novartis Overview
12.10.3 Novartis Respiratory Diseases Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Novartis Respiratory Diseases Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Novartis Recent Developments
12.11 Takeda
12.11.1 Takeda Corporation Information
12.11.2 Takeda Overview
12.11.3 Takeda Respiratory Diseases Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Takeda Respiratory Diseases Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Takeda Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Respiratory Diseases Drugs Industry Chain Analysis
13.2 Respiratory Diseases Drugs Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Respiratory Diseases Drugs Production Mode & Process
13.4 Respiratory Diseases Drugs Sales and Marketing
13.4.1 Respiratory Diseases Drugs Sales Channels
13.4.2 Respiratory Diseases Drugs Distributors
13.5 Respiratory Diseases Drugs Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Respiratory Diseases Drugs Industry Trends
14.2 Respiratory Diseases Drugs Market Drivers
14.3 Respiratory Diseases Drugs Market Challenges
14.4 Respiratory Diseases Drugs Market Restraints
15 Key Finding in The Global Respiratory Diseases Drugs Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer